Adenosine receptors in the nervous system: pathophysiological implications.
about
Association of the anxiogenic and alerting effects of caffeine with ADORA2A and ADORA1 polymorphisms and habitual level of caffeine consumptionAdenosine signaling and function in glial cellsAdenosine inhibits activity of hypocretin/orexin neurons by the A1 receptor in the lateral hypothalamus: a possible sleep-promoting effectAdenosine A2A receptors modulate acute injury and neuroinflammation in brain ischemiaAdenosine Deaminase Deficiency - More Than Just an ImmunodeficiencyThe Impact of Caffeine on the Behavioral Effects of Ethanol Related to Abuse and Addiction: A Review of Animal StudiesNew perspectives in signaling mediated by receptors coupled to stimulatory G protein: the emerging significance of cAMP efflux and extracellular cAMP-adenosine pathwayImmune Surveillance of the CNS following Infection and InjuryAdenosine A2A receptors mediate GABAergic inhibition of respiration in immature ratsRegulation of hippocampal cannabinoid CB1 receptor actions by adenosine A1 receptors and chronic caffeine administration: implications for the effects of Δ9-tetrahydrocannabinol on spatial memoryEffects of adenosine A2a receptor agonist and antagonist on cerebellar nuclear factor-kB expression preceded by MDMA toxicityHIF-1 alpha is an essential effector for purine nucleoside-mediated neuroprotection against hypoxia in PC12 cells and primary cerebellar granule neuronsOpioid-induced decreases in rat brain adenosine levels are reversed by inhibiting adenosine deaminaseCD73 is a major regulator of adenosinergic signalling in mouse brain.Adenosine hypothesis of schizophrenia--opportunities for pharmacotherapyAdenosine A(2A) receptors in psychopharmacology: modulators of behavior, mood and cognition.Enduring reversal of neuropathic pain by a single intrathecal injection of adenosine 2A receptor agonists: a novel therapy for neuropathic pain.Caffeine, cognitive functioning, and white matter lesions in the elderly: establishing causality from epidemiological evidence.Stimulation of the P2X7 receptor kills rat retinal ganglion cells in vivo.Methylxanthines, seizures, and excitotoxicity.Comparison of subjective and objective assessments of sleep in healthy older subjects without sleep complaints.3-(Fur-2-yl)-10-(2-phenylethyl)-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one, a novel adenosine receptor antagonist with A(2A)-mediated neuroprotective effects.Association of adenosine receptor gene polymorphisms and in vivo adenosine A1 receptor binding in the human brain.Caffeine: neuroprotective functions in cognition and Alzheimer's disease.Synthesis and pharmacological characterization of a new series of 5,7-disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazine derivatives as adenosine receptor antagonists: A preliminary inspection of ligand-receptor recognition processHydrogen sulfide inhibits A2A adenosine receptor agonist induced β-amyloid production in SH-SY5Y neuroblastoma cells via a cAMP dependent pathway.8-Benzyltetrahydropyrazino[2,1-f]purinediones: water-soluble tricyclic xanthine derivatives as multitarget drugs for neurodegenerative diseases.Sleep disturbances, psychiatric disorders, and psychotropic drugsHide and seek: a comparative autoradiographic in vitro investigation of the adenosine A3 receptorPurines and the Anti-Epileptic Actions of Ketogenic Diets.Plasticity of purine release during cerebral ischemia: clinical implications?Clinical neuropharmacology of drugs of abuse: a comparison of drug-discrimination and subject-report measures.NTS adenosine A2a receptors inhibit the cardiopulmonary chemoreflex control of regional sympathetic outputs via a GABAergic mechanism.Activation of adenosine₁ receptors induces antidepressant-like, anti-impulsive effects on differential reinforcement of low-rate 72-s behavior in ratsAdenosine and epilepsy: from therapeutic rationale to new therapeutic strategies.Working memory and the homeostatic control of brain adenosine by adenosine kinaseG-protein-coupled receptors in adult neurogenesis.Expression of striatal adenosine and dopamine receptors in mice deficient in the p50 subunit of NF-kappaBAdenosine receptor signaling in the brain immune system.Aging and Circadian Rhythms.
P2860
Q24602048-D42218C0-B348-48E4-A86A-6265985FA894Q24634273-BD7ABB8C-C99B-40C9-B855-730206CD2CB7Q24682013-96D9B34D-0EBE-46CB-AFA4-416E25822868Q26851322-AF96EB5B-C146-4D78-A141-42C22334EF45Q26865373-C5BBD532-DC00-4C5A-AD0B-DF407FFF930DQ27027640-8FFEFA8A-2B5A-4910-BB9A-732F709A0D7EQ28083279-49F3D517-9A73-4D7C-A3C3-433D21F71541Q28268038-43353211-26AF-4023-96C9-7A81172B8994Q28270571-5AEF95BC-610A-4D65-94EB-88E15C9109D8Q28295045-7094740F-3980-4F1E-8B5A-2E592AE4CF35Q28387121-8E284625-C158-4F12-A3E2-FACC27F695F4Q28578172-606BEBB5-F3E2-4426-9CED-0B95D6AF810FQ28581321-C9D12FB3-21AB-49B1-B72C-F512B3FB44BEQ30453460-72CA24E5-6C52-4684-99EE-1AC9B53A6ABCQ30457808-705D433A-C21D-4AF6-ABA4-E98B05D573F6Q30482913-C8C1A38E-515E-4AF5-B9E7-B6B969BA1320Q33562058-87188BBA-356C-4E36-9A88-C3CF12435BA9Q34088937-79EB068A-A9EF-44D4-B071-59CE3A77C230Q34139908-C0B22E45-39FC-4041-B598-AD497FB927BFQ34154555-F58D647F-4EBD-4CD7-8B84-27A6494B3A80Q34287042-D519E305-9C17-4944-9AC8-B0623BFBE7A6Q34365007-DDC22FDF-AED2-4221-AD26-98D6CDC465B7Q34499277-757FD6D8-E97C-4C7D-9DA6-4BE299FB7A62Q34948869-2062EC11-E996-4BAC-9EAE-36D997A511EDQ35020369-5071DB90-B9D5-4FAE-BF07-25629B010CD6Q35093638-96CB9303-E0B4-46C2-B945-EB044B073A72Q35166780-23B27D60-7AFA-4042-9268-11941322DD2FQ35236639-9A88DFCE-5D36-401A-AD9C-9AD43C99861BQ35244188-391E66BE-14F9-459D-B955-38C69B1B0A94Q35513799-9517C2FC-057D-4AB1-A204-0FE663EBD415Q35644634-7713B07B-3907-4AA4-A164-F92964858939Q35684589-AF8CD640-B668-488B-BC63-87424B76F99CQ35817836-AAD3532A-AB6A-40E3-816D-85B6DC668468Q35913141-F9A41F17-253C-4200-89EB-B17D087EE694Q35999731-1C83B809-F74C-4BB8-84D1-2B7E0642BE55Q36007799-BF0A3035-654A-4697-8A0B-5CFE9010BDCAQ36105469-DBD1768A-AEC9-436B-824E-6E103FE99EC6Q36155216-ED3E1DB3-78B7-48D7-8DA1-4BA7F888650DQ36242243-3F178E51-53F9-4073-ABA6-E6962A9C344FQ36289275-BEC2B2B7-0BAF-4B9A-9218-625492A39303
P2860
Adenosine receptors in the nervous system: pathophysiological implications.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Adenosine receptors in the nervous system: pathophysiological implications.
@ast
Adenosine receptors in the nervous system: pathophysiological implications.
@en
type
label
Adenosine receptors in the nervous system: pathophysiological implications.
@ast
Adenosine receptors in the nervous system: pathophysiological implications.
@en
prefLabel
Adenosine receptors in the nervous system: pathophysiological implications.
@ast
Adenosine receptors in the nervous system: pathophysiological implications.
@en
P2093
P50
P1476
Adenosine receptors in the nervous system: pathophysiological implications
@en
P2093
Ribeiro JA
Sebastião AM
de Mendonça A
P304
P356
10.1016/S0301-0082(02)00155-7
P577
2002-12-01T00:00:00Z